Search

Your search keyword '"M. .. Siciliano"' showing total 88 results
Start Over Author "M. .. Siciliano" Topic gastroenterology
88 results on '"M. .. Siciliano"'

1. Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance

Author

M. Siciliano, Giulia Morsica, Anna Claudia Pellicelli, Silvia Galli, F. Ceccherini-Silberstein, Fausto Baldanti, Bianca Bruzzone, R. Campoli, Giuliano Rizzardini, Vincenza Calvaruso, Gloria Taliani, V. Pace Palitti, C. Masetti, P Paba, Antonio Craxì, Filomena Morisco, Ennio Polilli, V.C. Di Maio, Martina Milana, William Gennari, C.F. Perno, Rossana Scutari, Aldo Bertoli, Valeria Cento, M. Andreoni, V. Boccaccio, Marianna Aragri, G.B. Gaeta, M. Lichtner, Caterina Pasquazzi, Vanni Borghi, Laura Ambra Nicolini, Renato Maserati, G. Fiorentino, Sergio Babudieri, Elisabetta Degasperi, Giustino Parruti, Mario Angelico, L. Foroghi, Valeria Ghisetti, Silvia Barbaliscia, Carlo Magni, Valeria Micheli, Elisabetta Teti, Nicola Coppola, Stefania Paolucci, L. Sarmati, R. D’Ambrosio, Pietro Lampertico, M. Puoti, N. Iapadre, Stefano Bonora, and V. Guarneri

Subjects
Natural resistance, Oncology, Focus (computing), medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Treatment outcome, Gastroenterology, medicine, Baseline (configuration management), DIRECT ACTING ANTIVIRALS, business
Published
2019

2. P.09.10 CIRRHOTIC PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY PRESENT INCREASED CEREBRAL VASCULAR RESISTANCE, WHICH REMAINS UNCHANGED AFTER MEDICAL TREATMENT

Author

B. Funaro, Andrea Lupascu, M.E. Ainora, G. Gasbarrini, Brigida E. Annicchiarico, M. Siciliano, Paolo Tondi, Alessandro Gasbarrini, Maurizio Pompili, Laura Riccardi, F.R. Ponziani, Maria Assunta Zocco, M. Garcovich, and A. Quadarella

Subjects
medicine.medical_specialty, Hepatology, Medical treatment, business.industry, Internal medicine, Gastroenterology, medicine, medicine.disease, business, Cerebral vascular resistance, Hepatic encephalopathy
Published
2018

3. Clinical impact of comorbidities in an Italian NAFLD cohort

Author

Emanuele Rinninella, Valeria Abbate, Giovanni Addolorato, F. Pizzolante, Luca Miele, M.E. Ainora, Laura Riccardi, A. Liguori, Giuseppe Marrone, F.R. Ponziani, N. De Matthaeis, Maria Assunta Zocco, A. Grieco, Maurizio Pompili, Marco Biolato, Maria Cristina Mele, Annalisa Tortora, M. Siciliano, G.L. Rapaccini, and Alessandro Gasbarrini

Subjects
medicine.medical_specialty, N/A, Hepatology, business.industry, Internal medicine, Settore MED/09 - MEDICINA INTERNA, Cohort, Gastroenterology, Medicine, business
Published
2019

4. Recipient perioperative cholesterolaemia and graft cholesterol metabolism gene expression predict liver transplant outcome

Author

Alfredo Cantafora, M. Siciliano, Manuela Merli, E. Poli, Lucia Parlati, Alessandro Corsi, Annarita Vestri, Massimo Rossi, Fabio Melandro, Adolfo Francesco Attili, Gianluca Mennini, Antonio Molinaro, Stefano Ginanni Corradini, Pasquale Berloco, Paolo Bianco, Edmondo Falleti, Davide Bitetto, and Pierluigi Toniutto

Subjects
Liver Cirrhosis, Male, Cirrhosis, medicine.medical_treatment, graft survival, Liver transplantation, Gastroenterology, serum cholesterol, chemistry.chemical_compound, hmgcr, Prospective Studies, liver transplantation, Reverse Transcriptase Polymerase Chain Reaction, Serine Endopeptidases, Confounding, Middle Aged, Cholesterol, Treatment Outcome, Italy, Creatinine, Regression Analysis, Female, Proprotein Convertases, Proprotein Convertase 9, medicine.medical_specialty, ldlr, Internal medicine, medicine, Humans, RNA, Messenger, npc1l1, srebf2, Perioperative Period, Retrospective Studies, pcsk9, Hepatology, business.industry, Proportional hazards model, cirrhosis, PCSK9, Retrospective cohort study, Perioperative, medicine.disease, cholesterolemia, Receptors, LDL, chemistry, Multivariate Analysis, Immunology, business
Abstract

Background & Aims We analysed for the first time whether recipient perioperative serum total cholesterol (sTC) concentration is associated with liver transplantation outcome. Methods We studied noncholestatic cirrhotics submitted to primary deceased-donor liver transplantation in a prospective group (n = 140) from Rome and in a validation retrospective cohort (n = 157) from Udine, Italy. Pre-ischaemia and post-reperfusion cholesterol metabolism gene mRNA was measured by RT-PCR in 74 grafts of the study group. Results At Cox regression analysis, independently from confounders including recipient MELD score, the recipient pre-operative sTC pooled quintiles 2–5, compared with the lowest quintile showed HR (95% CI) and significances for overall graft loss (GL) of 0.215 (0.104–0.444) P

Published
2013

6. P.09.23 COMMON CLINICAL COMORBIDITIES IN AN ITALIAN NAFLD COHORT

Author

Marco Biolato, Maurizio Pompili, Laura Riccardi, Maria Cristina Mele, Annalisa Tortora, M. Siciliano, Emanuele Rinninella, Giovanni Addolorato, A. Liguori, G.L. Rapaccini, A. Grieco, F.R. Ponziani, Giuseppe Marrone, M.E. Ainora, C. Khadim, N. De Matthaeis, L. Spiniello, Luca Miele, F. Pizzolante, Maria Assunta Zocco, and Alessandro Gasbarrini

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Cohort, Gastroenterology, Medicine, business
Published
2018

7. P.09.30 NEW DIRECT-ACTING ANTIVIRAL (DAA) THERAPY IMPACTS LIVER STIFFNESS MEASUREMENTS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION

Author

B. Funaro, M.E. Ainora, M. Garcovich, Maria Assunta Zocco, G. Gasbarrini, Annalisa Tortora, M. Siciliano, F.R. Ponziani, G. Gibiino, Maurizio Pompili, Alessandro Gasbarrini, T. Lembo, and Laura Riccardi

Subjects
Hepatology, Chronic hepatitis, business.industry, Liver stiffness, Immunology, Gastroenterology, Medicine, In patient, business, Virus, Direct acting
Published
2018

9. Comparison of Changes in Lipid Profile after Bilio-intestinal Bypass and Gastric Banding in Patients with Morbid Obesity

Author

F. Liguori, Stefano Ginanni Corradini, Adolfo Francesco Attili, Marco Badiali, Massimo Codacci Pisanelli, Gerald Salen, Carla Lubrano, Ashok K. Batta, M. Siciliano, A. Eramo, Alessandra Cornoldi, Giovanni Spera, and Antonio Grossi

Subjects
Male, total and ldl cholesterol, Endocrinology, Diabetes and Metabolism, Blood lipids, Gastroenterology, Feces, chemistry.chemical_compound, Prospective Studies, Prospective cohort study, gastric banding, cholecysto-jejunal anastomosis, Nutrition and Dietetics, medicine.diagnostic_test, Phytosterols, Biliopancreatic Diversion, bariatric surgery, bilio-intestinal bypass, cholesterol malabsorption, morbid obesity, Obesity, Morbid, Cholestanol, Cholesterol, Female, lipids (amino acids, peptides, and proteins), Adult, medicine.medical_specialty, Hypercholesterolemia, Gastric Bypass, Anastomosis, Bile Acids and Salts, Excretion, Jejunoileal Bypass, Internal medicine, medicine, Humans, Triglycerides, business.industry, Cholesterol, HDL, Cholesterol, LDL, medicine.disease, Obesity, Sterol, Endocrinology, chemistry, Surgery, business, Lipid profile, Follow-Up Studies
Abstract

Background: The presence of hypercholesterolemia is currently not considered a selection criteria for performing gastric restrictive or diversionary bariatric surgery. Methods: We prospectively investigated the effects of the bilio-intestinal bypass (BI-bypass) with a wide cholecysto-jejunal anastomosis and of adjustable gastric banding (AGB) on blood lipid concentrations in obese patients. To clarify the mechanism of the hypocholesterolemic effect of the BI-bypass, daily fecal sterol excretion was measured by gas-liquid chromatography (GLC). Results: At 1 year after BI-bypass compared to baseline, the hypercholesterolemic (n=18) and the normocholesterolemic (n=19) patients significantly reduced total (−38% and −27%, respectively), LDL (−47% and −24%, respectively) and HDL (−11% and −13%, respectively) cholesterol and total / HDL cholesterol ratio (−25% and −13%, respectively). At 1 year after AGB, the total / HDL cholesterol ratio was significantly decreased (−11%) compared to baseline in hypercholesterolemic (n=12) but not in normocholesterolemic (n=6) patients, while total and LDL cholesterol were not affected in both groups. At 3 years after BI-bypass compared to baseline, the hypercholesterolemic (n=9) and the normocholesterolemic (n=11) patients significantly reduced total (−43% and −28%, respectively) and LDL (−53% and −29%, respectively) cholesterol and total / HDL cholesterol ratio (−38% and −21%, respectively). The BI-bypass induced a significant (P

Published
2005

10. The gut microbiota of cirrhotic patients with poor nutritional status: Preliminary evidences

Author

Luca Masucci, F.R. Ponziani, Francesco Paroni Sterbini, Brigida E. Annicchiarico, Annalisa Tortora, Valentina Petito, M. Siciliano, Alessandra Palladini, Maurizio Pompili, Maurizio Sanguinetti, Cristina Graziani, Alessandro Gasbarrini, and Silvia Pecere

Subjects
Hepatology, biology, business.industry, Gastroenterology, Medicine, Physiology, Nutritional status, Gut flora, biology.organism_classification, business
Published
2016

11. Treatment failure to first-line direct antiviral (DAA) in HCV-related advanced liver disease: An Italian real-life urban setting

Author

C.F. Perno, F. Chiesara, D. Di Paolo, V. Gerardi, Alessandra Moretti, Francesca Ceccherini-Silberstein, Anna Claudia Pellicelli, Valeria Cento, C. Masetti, Paolo Rossi, Francesco Santopaolo, M. Siciliano, Mario Angelico, L. Fondacaro, Martina Milana, Raffaella Lionetti, Ilaria Lenci, and Gianpiero D’Offizi

Subjects
Liver disease, medicine.medical_specialty, Hepatology, business.industry, First line, Internal medicine, Gastroenterology, medicine, medicine.disease, business, Virology, Treatment failure
Published
2016

12. Clinical relevance of accurate HCV genotype and subtype assignment by NS3/NS5A/NS5B direct sequencing in the era of new direct acting antiviral agents

Author

Carlo Magni, Francesca Ceccherini-Silberstein, M. Puoti, Claudio Maria Mastroianni, A. Di Biagio, Marco Romano, Filomena Morisco, Giustino Parruti, Antonio Gasbarrini, Gloria Taliani, M. Siciliano, Simona Landonio, V.C. Di Maio, Martina Milana, Laura Gianserra, F. Deodati, Caterina Pasquazzi, M. Andreoni, J. Vecchiet, Valeria Cento, L. Lambiase, Marianna Aragri, Simona Francioso, E. D’Amico, Gabriella d'Ettorre, Giuliano Rizzardini, D. Di Paolo, Antonio Grieco, F. De Leonardis, A. Manunta, Ivana Maida, Anna Claudia Pellicelli, Mario Angelico, K. Yu La Rosa, Miriam Lichtner, P. Cacciatore, Cesare Sarrecchia, F.P. Antonucci, Aldo Bertoli, Valeria Micheli, Antonio Picciotto, Dante Romagnoli, Savino Bruno, Laura Ambra Nicolini, Ilaria Lenci, C.F. Perno, Marco Ciotti, Lorenzo Nosotti, Simona Marenco, Elisabetta Teti, M. Tontodonati, Maria Stella Mura, R. Campoli, Nicola Caporaso, S. Grieco, Sergio Babudieri, and Umberto Vespasiani-Gentilucci

Subjects
Genetics, chemistry.chemical_compound, NS3, Hepatology, chemistry, Direct sequencing, Genotype, Gastroenterology, Clinical significance, Biology, NS5A, NS5B, Direct acting
Published
2016

15. P.09.13: Hepatoma Arterial-Embolisation Prognostic Score Predicts Progression in Hepatocellular Carcinoma Treated by Radiofrequency Ablation Plus Transarterial Chemoembolization

Author

A. Grieco, Marco Biolato, M. Siciliano, Roberto Iezzi, G.L. Rapaccini, A. Liguori, F.G. Vaccaro, A. De Gaetano, Luca Miele, Giuseppe Marrone, C. Araneo, Alessandro Gasbarrini, and Maurizio Pompili

Subjects
medicine.medical_specialty, Hepatology, Radiofrequency ablation, law, business.industry, Hepatocellular carcinoma, Gastroenterology, medicine, Radiology, medicine.disease, business, Prognostic score, law.invention
Published
2017

16. P.10.7: The GUT Liver Axis after Liver Transplantation: Modification of Intestinal Permeability and Correlation with Infectious Complications and Patients Prognosis

Author

Alessandro Gasbarrini, F.R. Ponziani, A. Grieco, Maurizio Pompili, M. Siciliano, Salvatore Agnes, Rosalba Paone, Myrtò E. Carvelli, Gabriele Sganga, Venanzio Valenza, A.W. Avolio, and Margherita Lorusso

Subjects
medicine.medical_specialty, Intestinal permeability, Hepatology, business.industry, Internal medicine, medicine.medical_treatment, Gastroenterology, Medicine, Liver transplantation, business, medicine.disease
Published
2017

17. Natural HCV resistance is common in Italy and differently associated to genotypes

Author

Simona Landonio, Barbara Menzaghi, Giustino Parruti, T. Ruggiero, Valeria Cento, Francesca Ceccherini-Silberstein, Ilaria Lenci, M. Melis, Giuliano Rizzardini, Antonio Gasbarrini, P. Cacciatore, V. Pace Palitti, M.C. Sorbo, Ennio Polilli, Martina Milana, Alessandro Pieri, Laura Gianserra, Anna Claudia Pellicelli, P. Andreone, C. Masetti, Bianca Bruzzone, Simona Marenco, Elisabetta Teti, M. Andreoni, Gloria Taliani, Aldo Bertoli, Elisa Biliotti, Miriam Lichtner, Nicola Coppola, Vincenza Calvaruso, Fausto Baldanti, Stefania Paolucci, C.F. Perno, Carlo Magni, Sergio Babudieri, Valeria Micheli, Antonio Craxì, Filomena Morisco, V.C. Di Maio, Dante Romagnoli, Laura Ambra Nicolini, Mario Angelico, Loredana Sarmati, M. Siciliano, M. Puoti, N. Iapadre, Marianna Aragri, Vincenzo Vullo, Caterina Pasquazzi, and F. De Leonardis

Subjects
0301 basic medicine, Genetics, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Hepatology, Resistance (ecology), business.industry, Genotype, Gastroenterology, Medicine, 030211 gastroenterology & hepatology, business
Published
2017

18. HCV resistance test guided retreatments after protease inhibitors failures can induce maximal efficacy rate in real-life

Author

V. Cento, S. Barbaliscia, I. Lenci, T. Ruggiero, C. Masetti, C.F. Magni, V. Micheli, S. Paolucci, Y. Troshina, E. Biliotti, M. Milana, M. Melis, E. Teti, L. Lambiase, B. Menzaghi, L.A. Nicolini, S. Marenco, V.C. Di Maio, M. Aragri, A. Pecchioli, A. Bertoli, F.P. Antonucci, L. Sarmati, C. Sarrecchia, M. Macera, N. Coppola, E. Danieli, D. Romagnoli, A. Pellicelli, S. Bonora, S. Babudieri, A. Di Biagio, A. Picciotto, S. Novati, M. Siciliano, V. Messina, E. Claar, F. Baldanti, C. Pasquazzi, A. Ciancio, M. Puoti, V. Ghisetti, M. Andreoni, G. Taliani, G. Rizzardini, M. Angelico, C.F. Perno, and F. Ceccherini-Silberstein

Subjects
Resistance test, Protease, Hepatology, business.industry, medicine.medical_treatment, Gastroenterology, medicine, In real life, Pharmacology, business
Published
2017

19. The challenge of HCV-retreatment after DAA-failure: Italian real-life from VIRONET-C network

Author

V. Cento, S. Barbaliscia, V.C. Di Maio, C. Masetti, C. Minichini, C.F. Magni, V. Micheli, S. Marenco, L.A. Nicolini, B. Bruzzone, Y. Troshina, C. Baiguera, C. Dentone, V. Calvaruso, S. Paolucci, M. Melis, M. Aragri, A. Bertoli, I. Lenci, S. Landonio, M. Schiavini, L. Sticchi, T. Ruggiero, E. Polilli, V. Messina, A. Pellicelli, L. Boglione, R. Cozzolongo, M. Biolato, F. Morisco, M. Siciliano, G. Parruti, G. Barbarini, A. Craxì, S. Babudieri, M. Puoti, A. Ciancio, G. Rizzardini, N. Coppola, M. Angelico, C.F. Perno, and F. Ceccherini-Silberstein

Subjects
medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, medicine, Intensive care medicine, business
Published
2017

20. Improved virological outcomes and excellent safety profile in genotype 3 HCV-infected cirrhotic patients after an extended 24-weeks course of daclatasvir, sofosbuvir + ribavirin: insights from a real-life multicenter study

Author

Chiara Taibi, Raffaella Lionetti, Maurizio Pompili, Ubaldo Visco Comandini, Anna Rosa Garbuglia, Mario Angelico, Gianpiero D’Offizi, Paola Begini, Martina Milana, B. Imperatrice, Marzia Montalbano, M. Siciliano, and Ilaria Lenci

Subjects
medicine.medical_specialty, Daclatasvir, Hepatology, Sofosbuvir, business.industry, Ribavirin, 010102 general mathematics, 01 natural sciences, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, Safety profile, 0302 clinical medicine, chemistry, Multicenter study, Internal medicine, Genotype, medicine, 030212 general & internal medicine, 0101 mathematics, business, medicine.drug
Published
2017

21. Pegylated-Interferon and Ribavirin for Chronic Hepatitis C Virus Infection in Decompensated Cirrhotics Awaiting Liver Transplantation

Author

Salvatore Agnes, Antonio Gasbarrini, M. Siciliano, Brigida E. Annicchiarico, and Alfonso Wolfango Avolio

Subjects
Transplantation, medicine.medical_specialty, business.industry, Ribavirin, medicine.medical_treatment, virus diseases, Liver transplantation, medicine.disease, Gastroenterology, digestive system diseases, Virus, Liver disease, chemistry.chemical_compound, chemistry, Pegylated interferon, Interferon, Internal medicine, Immunology, Genotype, medicine, Adverse effect, business, medicine.drug
Abstract

Sustained virologic response (SVR) to the antiviral therapy for chronic hepatitis C virus infection before liver transplantation (LT) can prevent graft infection. Pegylated (PEG)- interferon (IFN) may ameliorate the SVR, improving the risk-to-benefit ratio of antiviral therapy in cirrhotics awaiting LT. From January 2001 to March 2009, 21 HCV- infected cirrhotics eligible for LT were treated with PEG-IFN alpha-2b (1.5 µg/kg weight/week) and ribavirin (800-1200 mg/day). Mean age was 53.7±7.9 years. There were 11 men. Eleven had genotype 1b. Child-Pugh score was 9.5±1.2, Model for End-Stage Liver Disease score 16.6±1.8. Besides virologic failure, full dosage and planned length of therapy were tolerated in 5 patients (23.8%). Adverse events occurred in all patients, life-threatening in 9 (42.9%). No patient died during treatment. Adverse events caused treatment withdrawal in 11 patients (52.4%), ribavirin and/or PEG-IFN reduction in 7 (33.3%). On an intention-to-treat basis, SVR was obtained in 4 patients (19.0%). None of the genotype 1 or 3 patients obtained SVR; 50.0% of genotype 2 patients obtained SVR. All patients with SVR experienced rapid virological response (RVR). Six patients (three nonresponders, two relapsers, one sustained responder) were transplanted; six died; four are awaiting LT; two are under evaluation for listening; three refused LT. The risk-to-benefit ratio is against treatment with PEG-IFN and ribavirin of severely decompensated genotype 1 cirrhotics. In contrast, antiviral therapy is probably beneficial in genotype 2 subjects, due to an expected SVR rate of 50%. However, one must carefully consider the high risk for severe adverse events.

Published
2011

22. Beneficial effect of sulphate-bicarbonate-calcium water on gallstone risk and weight control

Author

Maria Antonella Burza, Michela Mordenti, Bruno Sordi, Adriano De Santis, Luigi Iuliano, E. Poli, Adolfo Francesco Attili, M. Siciliano, Maria Pacini, Aldo Roda, Patrizia Simoni, Carolina Colliva, Barbara Caciotti, Stefano Ginanni Corradini, Flaminia Ferri, Corradini S.G., Ferri F., Mordenti M., Iuliano L., Siciliano M., Burza M.A., Sordi B., Caciotti B., Pacini M., Poli E., De Santis A., Roda A., Colliva C., Simoni P., and Attili A.F.

Subjects
medicine.medical_treatment, Blood lipids, Gallstones, chemistry.chemical_compound, Eating, High-density lipoprotein, Risk Factors, oxidative stress, Vitamin E, BILE-ACIDS, OXYSTEROLS, Bile acid, Sulfates, Gastroenterology, Gallbladder, General Medicine, Middle Aged, Postmenopause, GALLBLADDER MOTILITY, Cholesterol, POSTMENOPAUSAL WOMEN, Low-density lipoprotein, Female, medicine.medical_specialty, APOLIPOPROTEIN E4 GENOTYPE, INTESTINAL TRANSIT, Brief Article, medicine.drug_class, Bicarbonate, thermal water, SHOCK-WAVE LITHOTRIPSY, Bile Acids and Salts, Tap water, Internal medicine, medicine, gallstones, bile acid, body weight, Humans, Dyspepsia, Triglycerides, Aged, MINERAL-WATER, Body Weight, Water, CHOLESTEROL GALLSTONES, Atherosclerosis, Bicarbonates, Endocrinology, chemistry, Calcium, Constipation
Abstract

AIM: To investigate the effect of drinking sulphate-bicarbonate-calcium thermal water (TW) on risk factors for atherosclerosis and cholesterol gallstone disease. METHODS: Postmenopausal women with functional dyspepsia and/or constipation underwent a 12 d cycle of thermal (n = 20) or tap (n = 20) water controlled drinking. Gallbladder fasting volume at ultrasound, blood vitamin E, oxysterols (7-beta-hydroxycholesterol and 7-ketocholesterol), bile acid (BA), triglycerides, total/low density lipoprotein and high density lipoprotein cholesterol were measured at baseline and at the end of the study. Food consumption, stool frequency and body weight were recorded daily. RESULTS: Blood lipids, oxysterols and vitamin E were not affected by either thermal or tap water consumption. Fasting gallbladder volume was significantly (P < 0.005) smaller at the end of the study than at baseline in the TW (15.7 +/- 1.1 mL vs 20.1 +/- 1.7 mL) but not in the tap water group (19.0 +/- 1.4 mL vs 19.4 +/- 1.5 mL). Total serum BA concentration was significantly (P < 0.05) higher at the end of the study than at baseline in the TW (5.83 +/- 1.24 mu mol vs 4.25 +/- 1.00 mu mol) but not in the tap water group (3.41 +/- 0.46 mu mol vs 2.91 +/- 0.56 mu mol). The increased BA concentration after TW consumption was mainly accounted for by glycochenodeoxycholic acid. The number of pasta (P < 0.001), meat (P < 0.001) and vegetable (P < 0.005) portions consumed during the study and of bowel movements per day (P < 0.05) were significantly higher in the TW than in the tap water group. Body weight did not change at the end of the study as compared to baseline in both groups. CONCLUSION: Sulphate-bicarbonate-calcium water consumption has a positive effect on lithogenic risk and intestinal transit and allows maintenance of a stable body weight despite a high food intake.

Published
2012

23. P.16.8 ROLE OF TRANSCRANIAL DOPPLER (TCD) IN THE EVALUATION OF CEREBRAL HEMODYNAMIC IN CIRRHOTIC PATIENTS: CORRELATION WITH SEVERITY OF THE DISEASE AND MINIMAL HEPATIC ENCEPHALOPATHY (MHE) DEVELOPMENT

Author

Paolo Tondi, Davide Roccarina, Andrea Lupascu, Giuseppe Caracciolo, M. Garcovich, M. Siciliano, M.E. Ainora, Brigida E. Annicchiarico, D. Ferrarese, Maria Assunta Zocco, Alessandro Gasbarrini, and F. D'Aversa

Subjects
medicine.medical_specialty, Hepatology, business.industry, Cerebral hemodynamics, Gastroenterology, Medicine, Disease, Radiology, business, medicine.disease, Hepatic encephalopathy, Transcranial Doppler
Published
2014

24. OC.04.3 PATIENT-TARGETED AND MULTIDISCIPLINARY MANAGEMENT IMPROVES SURVIVAL IN PATIENTS WITH HCC: THE HEPATOCATT EXPERIENCE

Author

T.A. Di Rienzo, Emanuele Rinninella, Maurizio Pompili, Alessandro Gasbarrini, Mariachiara Campanale, S.G. Hepatocatt, M. Montagna, Valentina Cesario, G.L. Rapaccini, Brigida E. Annicchiarico, G. Gasbarrini, A. Grieco, F. D'Aversa, and M. Siciliano

Subjects
medicine.medical_specialty, Hepatology, business.industry, Multidisciplinary approach, Gastroenterology, medicine, In patient, Intensive care medicine, business
Published
2014

25. P.16.5 SAFETY AND EFFECTIVENESS OF PLASMA EXCHANGE IN SEVERE LIVER FAILURE

Author

Maurizio Pompili, A.W. Avolio, Valentina Cesario, S. Passalacqua, A. Grieco, T.A. Di Rienzo, F. D'Aversa, M. Siciliano, Alessandro Gasbarrini, Mariachiara Campanale, Giovanni Addolorato, P.M. Ferraro, Brigida E. Annicchiarico, G.L. Rapaccini, Salvatore Agnes, and G. D'Angelo

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, medicine, Liver failure, business
Published
2014

26. ONE MONTH POST-OPERATIVE SERUM INSULIN PREDICTS SERUM AMINOTRANSFERASE ELEVATION AND FIBROSIS PROGRESSION DUE TO HCV RECURRENCE AFTER LIVER TRANSPLANTATION

Author

D. Lilli, S. Ginanni Corradini, A. Onetti Muda, Maria Antonella Burza, F. Gentili, A. De Santis, P.B. Berloco, Antonio Molinaro, Massimo Rossi, Gianluca Mennini, A. Eramo, M. Siciliano, Manuela Merli, Adolfo Francesco Attili, and Giancarlo Ferretti

Subjects
medicine.medical_specialty, Hepatology, business.industry, medicine.medical_treatment, Serum insulin, Gastroenterology, Hcv recurrence, Liver transplantation, medicine.disease, Endocrinology, Fibrosis, Internal medicine, medicine, Post operative, business
Published
2009

27. Donor/recipient body surface area ratio as a novel predictor of graft survival after deceased donor liver transplantation

Author

Massimo Rossi, A.F. Attili, S. Ginanni Corradini, M. Siciliano, Manuela Merli, Carlo Pirazzi, Luca Poli, Antonio Molinaro, Flaminia Ferri, Maria Antonella Burza, Michela Giusto, P.B. Berloco, and Francesco Pugliese

Subjects
Body surface area, medicine.medical_specialty, Deceased donor, Hepatology, business.industry, medicine.medical_treatment, Gastroenterology, medicine, Graft survival, Liver transplantation, business, Surgery
Published
2009

28. Older donor age is associated with increased donor oxidative stress and failure to restore basal total protein graft content after ischemia reperfusion injury in human liver transplantation

Author

Luigi Iuliano, A.F. Attili, Antonio Molinaro, Gianluca Mennini, Carlo Pirazzi, S. Ginanni Corradini, R. Monticolo, M. Siciliano, Manuela Merli, P.B. Berloco, Massimo Rossi, E. Costi, and Maria Antonella Burza

Subjects
medicine.medical_specialty, Hepatology, Human liver, business.industry, Gastroenterology, Ischemia, medicine.disease_cause, medicine.disease, Donor age, Transplantation, Basal (phylogenetics), Endocrinology, Internal medicine, Anesthesia, medicine, business, Reperfusion injury, Oxidative stress, Total protein
Published
2008

29. Early hepatocyte C4d expression and failure to restore basal hepatic total protein content after ischaemia–reperfusion are associated with 1-year graft loss in human liver transplantation

Author

P. Barsotti, A. Onetti Muda, P.B. Berloco, M. Siciliano, Manuela Merli, Antonio Molinaro, R. De Marco, S. Ginanni Corradini, A.F. Attili, N. Gualtieri, and Massimo Rossi

Subjects
Aorta, medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, Albumin, Ischemia, medicine.disease, Complement system, Surgery, Andrology, Transplantation, Basal (phylogenetics), medicine.anatomical_structure, Hepatocyte, medicine.artery, Immunohistochemistry, Medicine, business
Abstract

Background and aims. Hepatic expression of several proteins, includng albumin, is reduced during ischaemia and restored upon reperfusion n human liver transplantation (LT) [J Pathol 2005;207:111–8]. Compleent activation during ischaemia reperfusion (IR) injury has been reported n renal, liver, intestine and heart allografts. A link between proteolysis nd complement activation has been demonstrated in myocardial IR damge [Proteomics 2002;2:988–95]. To better elucidate the mechanism and rognostic significance of complement activation in hepatic IR injury we easured early changes of liver graft C4d expression and total protein ontent (TP) during LT. Methods. Liver graft samples were obtained from heartbeating donors efore the aorta was clamped (T1) and 2 h after reperfusion in the recipint (T2) during primary whole organ LT. TP was measured by the Bio-Rad rotein assay method in freeze-dried liver homogenates from 47 grafts. In a ubgroup of 29 grafts C4d immunohistochemistry was performed on paraffin ections and positive hepatocytes were scored on a semiquantitative scale. he data were evaluated comparing grafts which were lost (LG) or survivng (SG) at 1-year follow-up. Intergroup differences were assessed by the ann–Whitney U-test. Correlations were analysed by the Spearman rank est. Results. LG (n= 10) had a significantly (p< 0.05) higher difference etween TP in T1 and in T2 ( TP) than SG (n= 37) (31.55± 31.51 vs. .41± 33.16 g/mg dry liver, respectively). C4d hepatocyte immunohistohemistry was negative in both LG and SG T1 samples. LG (n= 9) showed significantly (p< 0.05) higher T2 C4d hepatocyte score than SG (n= 20) 4.44± 1.67 vs. 2.55± 2.28 C4d, respectively). A positive correlation was ound between T2 C4d hepatocyte score and TP (r= 0.547, p< 0.01). Conclusions. Early complement activation and impaired restoring of raft protein content after reperfusion are linked events in hepatic ischaemia eperfusion injury and are associated with graft loss within the first year after uman LT.

Published
2007

30. The anionic peptide fraction is present on the gallbladder apical epithelium and favours biliary cholesterol absorption

Author

C. Ripani, Denis Lairon, R. De Marco, Huguette Lafont, S. Ginanni Corradini, Nicole Domingo, Giovanni D. Tebala, M. Siciliano, P. Lechene de la Porte, F. Liguori, and Adolfo Francesco Attili

Subjects
Swine, Peptide, Enzyme-Linked Immunosorbent Assay, In Vitro Techniques, Epithelium, Absorption, chemistry.chemical_compound, In vivo, Albumins, Anionic peptide fraction, Bile, Cholesterol absorption, Gallbladder, medicine, Animals, Bile, chemistry.chemical_classification, Hepatology, Apolipoprotein A-I, Cholesterol, business.industry, Gallbladder, Calcium-Binding Proteins, Gastroenterology, Albumin, Molecular biology, In vitro, Immunoglobulin A, medicine.anatomical_structure, chemistry, Biochemistry, Immunohistochemistry, business, Apoproteins
Abstract

Background/aims We investigated (a) in vitro and in vivo the changes of biliary mass of the anionic peptide fraction, apolipoproteinA-I, immunoglobulin-A, albumin and cholesterol over time in the excluded gallbladder and (b) in vivo the localization in the gallbladder epithelium of the anionic peptide fraction and cholesterol absorbed from bile. Methods Native bile was substituted with pig bile containing radiolabeled cholesterol in the in vitro isolated intra-arterially perfused pig gallbladder (n = 9) and in vivo in anestethized pigs with excluded gallbladders (n = 6). The amount of cholesterol (scintillation counting) and proteins (enzyme-linked immunosorbent assay) in gallbladder bile were measured over time. The localization of the anionic peptide fraction and cholesterol absorbed from bile in the gallbladder epithelium was studied in vivo by immunohistochemistry and fluoro-phospho-imager analysis. Results The rate of biliary cholesterol disappeared from bile was a function of the initial concentration and of the biliary mass changes over time of the anionic peptide fraction, but not of that of the other biliary proteins. The anionic peptide fraction colocalized with biliary cholesterol absorbed by the gallbladder on the apical side of gallbladder epithelial cells. Conclusions These data indirectly suggest that biliary anionic peptide fraction could favour biliary cholesterol absorption by the gallbladder epithelium.

Published
2006

31. Graft HCV reinfection impairs the physiological increase of insulin hepatic extraction and pancreatic secretion rapidly occurring after liver transplantation

Author

A. Eramo, A.F. Attili, Maria Antonella Burza, Gilnardo Novelli, P.B. Berloco, F. Lignori, Giancarlo Ferretti, M. Siciliano, Manuela Merli, R. De Marco, Massimo Rossi, and S. Ginanni-Corradini

Subjects
medicine.medical_specialty, Hepatology, business.industry, Insulin, medicine.medical_treatment, Gastroenterology, Liver transplantation, Pancreatic secretion, Endocrinology, Internal medicine, Immunology, Hepatic extraction, Medicine, business
Published
2006

32. P.18.15 CONTRAST-ENHANCED ULTRASOUND EVALUATION OF TUMOR RESPONSE TO ANTI ANGIOGENETIC TREATMENT IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARINOMA

Author

G.L. Rapaccini, Giuseppe Caracciolo, Laura Riccardi, Maria Assunta Zocco, M. Garcovich, F.R. Ponziani, M.E. Ainora, Andrea Lupascu, Maurizio Pompili, Alessandro Gasbarrini, Brigida E. Annicchiarico, M. Siciliano, and Davide Roccarina

Subjects
medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, medicine, In patient, Radiology, Tumor response, business, Contrast-enhanced ultrasound
Published
2013

33. P.11.15 IMPACT OF PORTAL VEIN THROMBOSIS ON HEPATOCELLULAR CARCINOMA TREATMENT OUTCOME. THE HEPATOCAT GROUP EXPERIENCE

Author

A. De Gaetano, Davide Roccarina, Mariachiara Campanale, F.R. Ponziani, Giuseppe Caracciolo, G. Gasbarrini, Felice Giuliante, A.W. Avolio, T.A. Di Rienzo, M. Garcovich, Gianluca Ianiro, F. Barbaro, Emanuele Rinninella, Brigida E. Annicchiarico, R. Zaccaria, G. Sarno, G.L. Rapaccini, Maurizio Pompili, Alessandro Gasbarrini, Maria Assunta Zocco, Valentina Cesario, Giovanni Gigante, Annalisa Tortora, A. Grieco, M. Siciliano, F. D'Aversa, Gennaro Nuzzo, Salvatore Agnes, and A. Milani

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Hepatocellular carcinoma, Treatment outcome, Gastroenterology, medicine, medicine.disease, business, Portal vein thrombosis
Published
2013

34. P.13.7 COMPARISON BETWEEN TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) AND TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION COMBINED WITH PERCUTANEOUS RADIOFREQUENCY ABLATION (TACE-RFA) FOR TREATMENT OF INTERMEDIATE HEPATOCELLULAR CARCINOMA (HCC)

Author

Lorenzo Bonomo, Maurizio Pompili, F.R. Ponziani, A. Grieco, Roberto Iezzi, Valentina Cesario, F. D'Aversa, A. De Gaetano, T.A. Di Rienzo, Maria Assunta Zocco, Brigida E. Annicchiarico, G. Gasbarrini, A. Guerra, M. Siciliano, G.L. Rapaccini, Salvatore Agnes, F. Barbaro, Emanuele Rinninella, M. La Torre, Felice Giuliante, Laura Riccardi, Gennaro Nuzzo, Mariachiara Campanale, Giovanni Gigante, and Alessandro Gasbarrini

Subjects
medicine.medical_specialty, Percutaneous, Hepatology, business.industry, Radiofrequency ablation, Gastroenterology, medicine.disease, law.invention, law, Hepatocellular carcinoma, medicine, Radiology, Transcatheter arterial chemoembolization, business
Published
2013

35. F-29 Endothelial dysfunction in cirrhosis and its relationship with portal hypertension and liver failure

Author

Giuseppe Caracciolo, Brigida E. Annicchiarico, Maria Assunta Zocco, Andrea Lupascu, Alessandro Gasbarrini, M.E. Ainora, Davide Roccarina, F.R. Ponziani, M. Siciliano, and M. Garcovich

Subjects
medicine.medical_specialty, Cirrhosis, Hepatology, business.industry, Internal medicine, Gastroenterology, medicine, Liver failure, Portal hypertension, Endothelial dysfunction, medicine.disease, business
Published
2013

36. First post-transplant day ALT serum concentration predicts early hepatitis C recurrence after liver transplantation (LT)

Author

Andrea Onetti Muda, Paola Tanzilli, Giancarlo Ferretti, Rosanna De Marco, Stefano Ginanni Corradini, Pasquale Berloco, Massimo Rossi, Stefania Natalizi, Adolfo Francesco Attili, M. Siciliano, Manuela Merli, Francesco Nudo, and Massimo Iappelli

Subjects
medicine.medical_specialty, Hepatology, business.industry, medicine.medical_treatment, Gastroenterology, Hepatitis C, Liver transplantation, Serum concentration, medicine.disease, Post transplant, Internal medicine, Immunology, medicine, business
Published
2003

37. P.04.17 THE ROLE OF CONTRAST ENHANCED ULTRASOUND PERFUSION IMAGING AND DOPPLER INDICES IN THE NON-INVASIVE ASSESSEMENT OF LIVER FIBROSIS: A PRELIMINARY EXPERIENCE

Author

Brigida E. Annicchiarico, Maurizio Pompili, Annalisa Tortora, M. Siciliano, Alessandro Gasbarrini, F. Barbaro, F.R. Ponziani, Andrea Lupascu, Maria Assunta Zocco, and M. Garcovich

Subjects
medicine.medical_specialty, Hepatology, business.industry, Liver fibrosis, Non invasive, Gastroenterology, Perfusion scanning, symbols.namesake, symbols, Medicine, Radiology, business, Doppler effect, Contrast-enhanced ultrasound
Published
2012

38. P.08.13 REDUCED DOSE AND DURATION OF SORAFENIB TREATMENT ARE ASSOCIATED TO TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

Author

T.A. Di Rienzo, Brigida E. Annicchiarico, F. D'Aversa, Mariachiara Campanale, Maria Assunta Zocco, Emanuele Rinninella, Giovanni Gigante, Carlo Barone, Alessandro Gasbarrini, M. Garcovich, Giuseppe Caracciolo, Michele A. Basso, G. Gasbarrini, G. Sarno, F.R. Ponziani, M. Siciliano, and Valentina Cesario

Subjects
Oncology, medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, Sorafenib treatment, Reduced dose, medicine.disease, Tumor progression, Internal medicine, Hepatocellular carcinoma, medicine, In patient, business
Published
2012

39. F-23 Lack of response and tumor recurrence after multimodal repeated treatment for hepatocellular carcinoma similarly affect HCC patients survival. A HEPATOCAT group experience

Author

Giuseppe Caracciolo, Alessandro Gasbarrini, Maurizio Pompili, Maria Assunta Zocco, Valentina Cesario, A. Milani, T.A. DiRienzo, Salvatore Agnes, Felice Giuliante, Gennaro Nuzzo, G.L. Rapaccini, R. Zaccaria, G. Gasbarrini, A. De Gaetano, Annalisa Tortora, A. Grieco, V. Gigante, M. Siciliano, Emanuele Rinninella, F. D'Aversa, M. Garcovich, F.R. Ponziani, Brigida E. Annicchiarico, C. Campanale, and G. Sarno

Subjects
Oncology, medicine.medical_specialty, Repeated treatment, Hepatology, business.industry, Internal medicine, Hepatocellular carcinoma, Gastroenterology, medicine, business, Affect (psychology), medicine.disease, Tumor recurrence
Published
2012

40. T-21 Single-step balloon-occluded percutaneous radio-frequency thermal ablation (RFA) plus transcatheter arterial chemoembolization (TACE) for treatment of 'complex' unresectable hepatocellular carcinoma

Author

R. Iezzi, V. Cesario, M. Campanale, T.A. DiRienzo, G. Gigante, G. Caracciolo, E. Rinninella, F.R. Ponziani, M. La Torre, B.E. Annicchiarico, M. Siciliano, M. Pompili, A. Grieco, L. Miele, M. Santoro, G.L. Rapaccini, L. Riccardi, M.A. Zocco, A. Milani, A.M. De Gaetano, G. Gasbarrini, L. Bonomo, and A. Gasbarrini

Subjects
Hepatology, Gastroenterology
Published
2012

42. P.17.5 TREATMENT OF 'COMPLEX' UNRESECTABLE HEPATOCELLULAR CARCINOMA: PRELIMINARY RESULTS OF NEW THERAPEUTIC APPROACH (SINGLE-STEP BALLOON-OCCLUDED PERCUTANEOUS RADIO-FREQUENCY THERMAL ABLATION PLUS TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE-RFA)

Author

Maurizio Pompili, S.G. Hepatocatt, Valentina Cesario, Lorenzo Bonomo, A. Grieco, A. De Gaetano, Emanuele Rinninella, Mariachiara Campanale, M. Siciliano, F. Barbaro, Maria Assunta Zocco, T.A. Di Rienzo, G. D'Angelo, A. Guerra, G. Gasbarrini, G.L. Rapaccini, Brigida E. Annicchiarico, Massimiliano Nestola, Alessandro Gasbarrini, M. La Torre, Alessandro Posa, and Roberto Iezzi

Subjects
medicine.medical_specialty, Percutaneous, Hepatology, business.industry, Gastroenterology, Thermal ablation, Single step, medicine.disease, Balloon, Therapeutic approach, Hepatocellular carcinoma, medicine, Radiology, business, Transcatheter arterial chemoembolization
Published
2014

43. P.16.9 SHORT TREATMENT WITH RIFAXIMIN IMPROVES BLOOD CEREBRAL FLOW AT TRANSCRANIAL DOPPLER AND PSYCHOMETRIC TESTS IN CIRRHOTIC PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY

Author

M.E. Ainora, Giuseppe Caracciolo, M. Garcovich, Andrea Lupascu, F. D'Aversa, Maria Assunta Zocco, M. Siciliano, Brigida E. Annicchiarico, D. Ferrarese, Alessandro Gasbarrini, Paolo Tondi, and Davide Roccarina

Subjects
Blood cerebral flow, medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, medicine.disease, Surgery, Transcranial Doppler, Rifaximin, chemistry.chemical_compound, chemistry, Internal medicine, medicine, Cardiology, business, Hepatic encephalopathy, Psychometric tests
Published
2014

44. P.16.15 FEASIBILITY AND ACCURACY OF ELASTPQ® SHEAR WAVE ELASTOGRAPHY TECHNIQUE AND DOPPLER INDICES IN THE NON-INVASIVE ASSESSEMENT OF LIVER FIBROSIS: A PRELIMINARY EXPERIENCE

Author

Giuseppe Caracciolo, Alessandro Gasbarrini, M. Siciliano, M.E. Ainora, Maurizio Pompili, M. Garcovich, Maria Assunta Zocco, Brigida E. Annicchiarico, F.R. Ponziani, Laura Riccardi, A. Grieco, and Davide Roccarina

Subjects
medicine.medical_specialty, symbols.namesake, Shear wave elastography, Hepatology, business.industry, Liver fibrosis, Non invasive, Gastroenterology, symbols, Medicine, Radiology, business, Doppler effect
Published
2014

45. P.17.4 DOWNSTAGING THERAPY IN PATIENTS WITH INTERMEDIATE STAGE HCC (BCLC B) AS BRIDGE FOR TRANSPLANTATION: THE HEPATOCATT EXPERIENCE

Author

A. Grieco, F. D'Aversa, Brigida E. Annicchiarico, A.W. Avolio, Salvatore Agnes, Alessandro Gasbarrini, G. D'Angelo, G.L. Rapaccini, F. Barbaro, G. Gasbarrini, M. Siciliano, Roberto Iezzi, T.A. Di Rienzo, Mariachiara Campanale, S.G. Hepatocatt, A. De Gaetano, Maurizio Pompili, and Valentina Cesario

Subjects
Transplantation, medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, Medicine, In patient, business, Bridge (interpersonal), Intermediate stage, Surgery
Published
2014

46. Early viral dynamics in HCV-RNA decay and NS3-resistance development predict the risk of failure to first-generation protease inhibitors

Author

Giustino Parruti, Gloria Taliani, Simona Francioso, Ilaria Lenci, F.P. Antonucci, Claudio Maria Mastroianni, Simona Landonio, Laura Ambra Nicolini, Ivana Maida, Valeria Micheli, Antonio Picciotto, D. Di Paolo, Giuliano Rizzardini, Lorenzo Nosotti, F. De Leonardis, Marco Massari, Antonio Gasbarrini, Anna Claudia Pellicelli, Sergio Babudieri, A. Manunta, Jacopo Vecchiet, Francesca Ceccherini-Silberstein, M. Tontodonati, A. De Maria, Ennio Polilli, Maria Stella Mura, Tamara Ursini, Cesare Sarrecchia, Simona Marenco, A. Di Biagio, Marianna Aragri, Massimo Andreoni, Mario Angelico, Valeria Cento, Fosca Niero, Alessandra Mangia, Annalisa Tortora, Alessandro Mancon, M. Siciliano, V.C. Di Maio, Carlo Federico Perno, Carlo Magni, Claudio Viscoli, and Aldo Bertoli

Subjects
NS3, Protease, Hepatology, Resistance development, Viral dynamics, business.industry, medicine.medical_treatment, Gastroenterology, Medicine, business, Virology, First generation
Published
2014

48. 492 REGULATION OF LIVER GRAFT CHOLESTEROL SYNTHESIS AND UPTAKE AFFECTS THE OUTCOME OF HUMAN LIVER TRANSPLANTATION

Author

M. Siciliano, Alfredo Cantafora, Carlo Pirazzi, Manuela Merli, A.F. Attili, Francesco Pugliese, S. Ginanni Corradini, P.B. Berloco, Lucia Parlati, Michela Giusto, Ida Blotta, Marcos A. Rossi, Antonio Molinaro, and Gianluca Mennini

Subjects
Liver graft, Transplantation, Cholesterol synthesis, medicine.medical_specialty, Hepatology, Human liver, business.industry, Internal medicine, medicine, business, Gastroenterology
Published
2010

49. 579 ENDOTHELIAL DYSFUNCTION IN CIRRHOSIS AND ITS RELATIONSHIP WITH PORTAL HYPERTENSION AND LIVER FAILURE

Author

M.E. Ainora, Andrea Lupascu, M. Siciliano, Giuseppe Caracciolo, Davide Roccarina, Alessandro Gasbarrini, M. Garcovich, Eleonora Annicchiarico, Maria Assunta Zocco, and F.R. Ponziani

Subjects
medicine.medical_specialty, Cirrhosis, Hepatology, business.industry, Internal medicine, Liver failure, Medicine, Portal hypertension, Endothelial dysfunction, business, medicine.disease, Gastroenterology
Published
2013

Catalog

Books, media, physical & digital resources
See catalog results